Endometriosis is a devastating and heartbreaking condition for millions of women worldwide. It is estimated that 10% of the total female population are affected, of which many will experience the painful and destructive symptoms. These symptoms can include severe pelvic pain, abnormal and unpredictable menstrual cycles, nausea, and fatigue. Endometriosis is also one of the leading causes of infertility in women. Unfortunately, most women are not correctly diagnosed with this condition until many years after it appears, and treatments are invasive, uncomfortable, expensive, and commonly ineffective. Right now, there is no cure. No cure means that many women are living in constant pain with no options for relief, and many find themselves unable to conceive.
Juneau Biosciences, a biotechnology company in Salt Lake City, Utah, has started a genetic research project to find out which genes predispose women to developing endometriosis. This study is being done by comparing the DNA of women diagnosed with varying severities of endometriosis against the DNA of women without endometriosis. The genes that are associated with this condition, referred to as markers, are valuable in that once known, a diagnostic test can be manufactured that can accurately predict the likelihood of an individual developing endometriosis BEFORE any symptoms arise. If a woman finds that she is at a high risk level, she can consult with her doctor to take preventative measures against the disease, such as being put on a low-hormone birth control method to manage the endometriosis. Increased understanding of the causes of endometriosis also open opportunities for the development of an effective cure.
For more information about this study, visit the study page at www.endtoendo.com.